Tumor response is an independent prognostic factor in patients (pts) treated for metastatic renal cell carcinoma (mRCC)

被引：0
|
作者：
Gruenwald, V. [1 ]
Lin, X. [2 ]
Kalanovic, D. [3 ]
McKay, R. [4 ]
Perkins, J. [5 ]
Simantov, R. [5 ]
Choueiri, T. [4 ]
机构：
[1] Hannover Med Sch, Hannover, Germany
[2] Pfizer Oncol, Stat, San Diego, CA USA
[3] Pfizer Pharma GmbH, Med Oncol, Berlin, Germany
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Pfizer Inc, Oncol Med Affairs, New York, NY USA
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2702
引用
收藏
页码：S642 / S642
页数：1
相关论文
共 50 条
  • [1] Tumor burden as an independent prognostic factor in metastatic renal cell carcinoma (mRCC).
    Escudier, Bernard J.
    Iacovelli, Roberto
    Lanoy, Emilie
    Albiges, Laurence
    Fizazi, Karim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [2] Prognostic impact of lymphnode metastasis in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Ivanyi, P.
    Tiemann, M. -L.
    Eggers, H.
    Reuter, C.
    Peters, I.
    Kuczyk, M.
    Ganser, A.
    Gruenwald, V.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 80 - 80
  • [3] Pre-existing hypertension is an independent prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with sunitinib (SU)
    Derosa, Lisa
    Izzedine, Hassane
    Le Teuff, Gwenael
    Albiges, Laurence
    Escudier, Bernard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Association of tumor burden characteristics with outcomes in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib
    Golshayan, A. R.
    Elson, P.
    Wood, L. S.
    Garcia, J. A.
    Dreicer, R.
    Rini, B. I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] External validation of a sunitinib prognostic nomogram in patients (pts) with metastatic renal cell carcinoma (mRCC).
    Yu, Changhong
    Kattan, Michael W.
    Hutson, Thomas E.
    Hudes, Gary R.
    Yuan, Jinyu
    Valota, Olga
    Motzer, Robert John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Time from nephrectomy (Nx) as an independent prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with targeted therapies (TTs)
    Procopio, Giuseppe
    Iacovelli, Roberto
    Verzoni, Elena
    Grassi, Paolo
    Testa, Isabella
    Garanzini, Enrico
    Nicolai, Nicola
    De Braud, Filippo G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [7] Early tumor shrinkage (eTS) as a predictive and prognostic factor in metastatic renal cell carcinoma (mRCC).
    Gruenwald, Viktor
    Lin, Xun
    Kalanovic, Daniel
    Simantov, Ronit
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] Are there geographic differences in the outcome of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib (su)?
    Keizman, Daniel
    Ish-Shalom, Maya
    Maimon, Natalie
    Gottfried, Maya
    Pili, Roberto
    Hammers, Hans J.
    Eisenberger, Mario A.
    Sinibaldi, Victoria J.
    Boursi, Ben
    Weitzen, Rony
    Hayat, Henry
    Peer, Avivit
    Neumann, Avivit
    Kovel, Svetlana
    Sella, Avishay
    Mermershtain, Wilmosh
    Rouvinov, Keren
    Berger, Raanan
    Carducci, Michael Anthony
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] Are there geographic differences in the outcome of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib (su)?
    Keizman, Daniel
    Ish-Shalom, Maya
    Maimon, Natalie
    Gottfried, Maya
    Pili, Roberto
    Hammers, Hans J.
    Eisenberger, Mario A.
    Sinibaldi, Victoria J.
    Boursi, Ben
    Weitzen, Rony
    Hayat, Henry
    Peer, Avivit
    Neumann, Avivit
    Kovel, Svetlana
    Sella, Avishay
    Mermershtain, Wilmosh
    Roubinov, Keren
    Berger, Raanan
    Carducci, Michael Anthony
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [10] Active surveillance (AS) in the management of patients (pts) with metastatic renal cell carcinoma (mRCC).
    Ivanyi, Philipp
    Eggers, Hendik
    Seidel, Christoph Alexander
    Reuter, Christoph
    Ganser, Arnold
    Gruenwald, Viktor
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345